To say that 2020 was an annus horribilis would be an understatement.
But if you had been in a coma for the past twelve months, looking at the activity in university venturing would not give the game away. As you can see in our annual review – and hear from thought leaders from all over the world – spinouts everywhere thrived despite the worst health crisis in living memory.
Biontech and Moderna – two spinouts that long-term readers will have been familiar with years ago – are now household names,…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
